Ouagadougou is the capital of Burkina Faso and the administrative, communications, cultural, and economic centre of the nation. It is also the country's largest city, with a population of 2,453,496 in 2019. The city's name is often shortened to Ouaga. The inhabitants are called ouagalais.

During the past decade, Université de Ouagadougou conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Université de Ouagadougou" #1 collaborator was "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 1 trials as a collaborator, "Liverpool School of Tropical Medicine" with 1 trials as a collaborator, "Medical Research Council Unit, The Gambia" with 1 trials as a collaborator, "Medical Research and Training Centre, Mali" with 1 trials as a collaborator and "Navrongo Health Research Centre, Ghana" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Université de Ouagadougou" are "Anaemia" (1 trials), "HIV Infections" (1 trials), "Malaria" (1 trials) and "Pregnancy" (1 trials). Many other conditions were trialed in "Université de Ouagadougou" in a lesser frequency.

Most popular intervention types in "Université de Ouagadougou" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Intermittent screening and treatment of malaria in pregnancy (IST)" (1 trials), "Lamivudine (3TC)" (1 trials), "SP-IPTp" (1 trials) and "lopinavir/ritonavir (LPV/r)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Université de Ouagadougou" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Université de Ouagadougou". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Université de Ouagadougou, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Université de Ouagadougou, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".